Develop Business Strategies Of Head and Neck Cancers Market Forecast to 2026

"The Latest Research Report Head and Neck Cancers: Epidemiology Forecast to 2026 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

Head and neck cancers usually begin in the squamous cells that line the moist mucosal surfaces of the tissues and organs of the head and neck-more than 83% of all oral cavity and pharynx cancers are squamous cell carcinomas. They are the ninth most common malignancy in the world, with high mortality rates in the developing countries.

10-year epidemiological forecasts of the diagnosed incident cases of HNCs are provided. HNCs are grouped into the following, in this report -
1. Cancers of the lip, oral cavity, pharynx, and larynx cancer (ICD-10 = C00-C06, C09-C10, C12-C14, and C32)
2. Oropharynx cancer (ICD-10 = C10)
3. Nasopharynx cancer (ICD-10 = C11)
4. Other head and neck cancer sites - salivary gland and nose, sinuses, and other related structures cancer (ICD-10 = C07-C08 and C30-C31)

To forecast the diagnosed incident cases and the five-year diagnosed prevalent cases of HNCs in the 7MM, GlobalData epidemiologists selected nationally representative, population-based studies or cancer registries that provided the diagnosed incidence or observed or relative survival rates for these cancers in the 7MM. GlobalData estimate that the diagnosed incident cases of HNCs in the 7MM will increase from 154,300 cases in 2016 to 177,034 cases in 2026, at an Annual Growth Rate (AGR) of 1.47% over the forecast period. Throughout the forecast period, the US will have the highest number of diagnosed incident cases of HNCs, followed by Japan.

Get Sample Copy of this report @ https://www.marketresearchreports.biz/sample/sample/1769928

Scope

- The Head and Neck Cancers Epidemiology report provides an overview of the risk factors and global trends of head and neck cancers in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
- 10-year epidemiological forecasts of the diagnosed incident cases of HNCs are provided and segmented into the following groups: cancers of the lip, oral cavity, pharynx, and larynx cancer; oropharynx cancer; nasopharynx cancer; and other sites. Histology distribution and, clinical stage at diagnosis, risk factors, and diagnosed five-year prevalent cases are available for some of the groups.
- The head and neck cancers epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The head and neck cancers epidemiology report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global head and neck cancers market.
- Quantify patient populations in the global head and neck cancers market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for head and neck cancers therapeutics in each of the markets covered.
- Understand magnitude of patient groups in each of the cancer subgroups and their relevant patient characteristics.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Head and Neck Cancers: Executive Summary 5
2.1 Related Reports 6

3 Epidemiology 7
3.1 Disease Background 7
3.2 Risk Factors and Comorbidities 8
3.3 Global and Historical Trends 9
3.4 Forecast Methodology 13
3.4.1 Sources 13
3.4.2 Forecast Assumptions and Methods - Population 18
3.4.3 Forecast Assumptions and Methods - Diagnosed Incident Cases of HNCs 18
3.4.4 Forecast Assumptions and Methods - Five-Year Diagnosed Prevalent Cases of HNCs 22
3.4.5 Forecast Assumptions and Methods - Diagnosed Incident Cases of HNCs by Histology Distribution 23
3.4.6 Forecast Assumptions and Methods - Diagnosed Incident Cases of HNC by Clinical Stages at Diagnosis for Squamous Cell Carcinoma 24
3.4.7 Forecast Assumptions and Methods - Diagnosed Incident Cases of Oropharynx Cancer by Risk Factor (HPV+ and HPV-) 24
3.4.8 Forecast Assumptions and Methods - Diagnosed Incident Cases of Nasopharynx Cancer by Risk Factor (EBV+) 25

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1769928

3.5 Epidemiological Forecast for HNCs (2016-2026) 25
3.5.1 Diagnosed Incident Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer 25
3.5.2 Age-Specific Diagnosed Incident Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer 26
3.5.3 Sex-Specific Diagnosed Incident Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer 27
3.5.4 Diagnosed Incident Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer by Histology Distribution 28
3.5.5 Diagnosed Incident Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer by Clinical Stage at Diagnosis for Squamous Cell Carcinoma 29
3.5.6 Five-Year Diagnosed Prevalent Cases of Lip, Oral Cavity, Pharynx, and Larynx Cancer 30
3.5.7 Diagnosed Incident Cases of Oropharynx Cancer by Histology Distribution and by Risk Factor (HPV) 31
3.5.8 Diagnosed Incident Cases of Nasopharynx Cancer by Histology Distribution and by Risk Factor (EBV) 31
3.5.9 Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer 32
3.5.10 Age-Specific Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer 33
3.5.11 Sex-Specific Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer 34
3.5.12 Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer by Histology Distribution 35
3.5.13 Diagnosed Incident Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer by Clinical Stage at Diagnosis for Squamous Cell Carcinoma 36
3.5.14 Five-Year Diagnosed Prevalent Cases of Salivary Gland and Nose, Sinuses, and Other Related Structures Cancer 37
3.6 Discussion 38
3.6.1 Epidemiological Forecast Insight 38
3.6.2 Limitations of the Analysis 38
3.6.3 Strengths of the Analysis 39

4 Appendix 40
4.1 Bibliography 40
4.2 About the Authors 44
4.2.1 Epidemiologist 44
4.2.2 Reviewers 44
4.2.3 Global Director of Therapy Analysis and Epidemiology 45
4.2.4 Global Head and EVP of Healthcare Operations and Strategy 45
4.3 About GlobalData 46
4.4 Contact Us 46
4.5 Disclaimer 47

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

This release was published on openPR.